Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06919224 · ClinicalTrials.gov registry record · NA

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

A NA study of Sickle Cell Disease, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
287
Enrollment target
4
Study locations

NCT06919224 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 287 participants, roughly in line with the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target. The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06919224, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
287 participants
Enrollment target
4
Study locations

Study Summary

In a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) with patient-facing SCD-specific guidelines through an mHealth application with booklets will decrease acute healthcare utilization and be cost-effective over booklets with the guidelines alone. Our team, head will test our hypotheses with the following aims: Aim 1: evaluate the effectiveness of the patient-facing guidelines mHealth app + booklet intervention to decrease acute healthcare utilization (hospitalizations, emergency room visits, and day hospital visits) in adults with SCD over the standard care in a randomized controlled trial, Aim 2: evaluate the implementation outcomes of the mHealth app + booklet using the capability, opportunity, and motivation-behavior (COM-B) and reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) frameworks, and Aim 3: evaluate the cost-effectiveness of patient-facing mHealth app + booklets vs. standard care in adults with SCD. is hybrid effectiveness-implementation trial design, according to the COM-B and RE-AIM frameworks with a mixed-methods approach, will give valuable insights into the effects, facilitators, and barriers to the implementation that will influence the effects of the patient-facing guidelines intervention.

Conditions Studied

Sickle Cell Disease

Interventions

  • OTHER mHealth app + booklets

Study Locations (4)

Illinois

  • University of Illinois at Chicago - Chicago

Missouri

  • Washington University St. Louis - St Louis

Ohio

  • The Ohio State University Medical Center - Columbus

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 287 participants
Start Date 2026-01-13
Est. Completion 2032-03
Phase NA

Sponsor

Ohio State University

552 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06919224

The ClinicalTrials.gov registry entry for NCT06919224 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which mHealth app + booklets is the first listed.

NCT06919224 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Illinois, Missouri, Ohio.

Frequently Asked Questions

What is clinical trial NCT06919224 about?

NCT06919224 is a clinical study titled "Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease". In a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) with patient-facing SCD-specific guidelines through an mHealth application with booklets will decrease acute healthcare utilization and be co...

What is the current status of trial NCT06919224?

This trial is currently recruiting. It is a NA study. The enrollment target is 287 participants. The study started on 2026-01-13. Estimated completion is 2032-03.

What conditions does trial NCT06919224 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT06919224?

The interventions under investigation include: mHealth app + booklets (OTHER).

Who is sponsoring clinical trial NCT06919224?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06919224 being conducted?

This trial has 4 study locations across Illinois, Missouri, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sickle Cell Disease

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.